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Encephalomyocarditis virus (EMCV) infection leads to many diseases including encephalitis, myocarditis and diabetes in its 
natural host, the mouse. In this study, we generated four cDNA clones with a point mutation at position 100 of VP1. The 
amino acids isoleucine, alanine, serine and proline were substituted with threonine in the four different clones of EMCV strain 
BJC3 by site-specific mutagenesis, and viable viruses were rescued. Although all mutants and wild-type viruses display dif-
ferent plaque morphologies, they replicate comparably in BHK-21 cells. The pathogenicity of the mutated viruses was system-
atically analyzed to investigate the importance of this amino acid in the viral pathogenicity and disease phenotype of EMCV 
infection in mice. The results showed that the isoleucine- (T1100I) and proline-mutated viruses (T1100P) exhibited a reduced 
mortality, lower cerebral virus loads and alleviated brain damage while the viruses with serine (T1100S) and alanine (T1100A) 
substitutions displayed similar properties as the wild-type virus. These findings indicate that the amino acid at position 100 of 
VP1 is important for EMCV in vivo infection, and its mutation alters the pathogenicity of viral infection in mice. 
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Encephalomyocarditis virus (EMCV) is a prototype member 
of the genus Cardiovirus, family Picornaviradae. EMCV 
can infect many vertebrates including rodents, pigs, and 
primates including humans [1]. Since the initial isolation of 
EMCV from a chimpanzee that died of acute myocarditis in 
1945, a number of virus strains have been reported world-
wide, especially after an outbreak of EMCV infection in 
swine farms in the US and European countries [2]. EMCV 
variants with indistinguishable serological reactions can 
cause clinical symptoms that are different among or even 
within animal species, and their pathogenicities were found 
to be strain-dependent [3]. Some strains of EMCV were 
fatal in piglets, causing acute myocarditis. In sows, EMCV 
caused reproductive failure leading to abortion and fetal 
death [4]. In mice, EMCV can cause various diseases in-
cluding acute neurological disorders, diabetes and myocar-
ditis, while some strains, like EMC-B and G424/90, gener-
ated no visible symptoms following infection [5]. To date, 
the mechanisms involving virulence and pathogenesis of 
EMCV remain unknown.  
The three major capsid proteins, VP1, VP2 and VP3 that 
constitute the external virion shell of picornaviruses, are 
considered to play a pivotal role in viral infection and host 
recognition [6]. These proteins are so important that even a 
single amino acid variation can result in a profound effect 
on viral pathogenesis [7]. During the investigation of insu-
lin-dependent diabetes mellitus (IDDM) in a mouse model 
induced by infection with EMCV variants, it was found that 
the amino acids at position 152 of VP1 determined the gain 
or loss of the diabetogenicity by affecting the effectiveness 
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of binding to the surface of pancreatic β-cells [8]. Further-
more, studies of Theiler’s murine encephalomyelitis virus 
(TMEV), a ‘close relative’ of EMCV in the genus Cardio-
virus, demonstrated that the amino acids on the loops ex-
posed to the surface of the virion were important disease 
determinants [9]. 
The three-dimensional structure of Mengo virus and 
TMEV has been documented by X-ray crystallography, and 
the structural functions of the exterior surface depressions 
and prominent loops in viral attachment and receptor binding 
were analyzed and hypothesized [10]. Based on the high 
conformational homology of VP1 among Mengo virus, 
EMCV and TMEV, as well as previous results, it is postu-
lated that the conformational change of the VP1 loop is a 
result of amino acid substitution, possibly contributing to 
different disease phenotypes in EMCV infection. Therefore, 
we selected the amino acid at position 100, a threonine in 
loop II of VP1 in EMCV, and constructed four mutated 
cDNA clones by introducing several single point mutations 
using site-directed mutagenesis. We systematically analyzed 
the pathogenicity of the rescued viruses to investigate the 
role of specific amino acids in the pathogenicity of the virus. 
1  Materials and methods 
1.1  Cells and virus 
BHK-21 cells (China Institute of Veterinary Drug Control, 
Beijing, China) were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM; GIBCO™, Invitrogen Corpora-
tion, Carlsbad, CA, USA) supplemented with 10% fetal 
bovine serum (FBS; GIBCO™, Invitrogen Corporation),  
10 mmol L−1 Hepes, 100 mg mL−1 streptomycin (pH 7.4), 
100 U mL−1 penicillin at 37°C/5% CO2. EMCV strain BJC3 
used in the study was isolated from an aborted swine fetus, 
from Beijing in 2005, and its genomic sequence was deter-
mined and deposited in GenBank (Accession No. 
DQ464062) [11].  
1.2  Laboratory animals 
Eight-week-old BALB/c mice (Beijing Laboratory Animal 
Research Centre) were used for animal trials in this study. 
All the animal trials were approved by the Beijing Labora-
tory Animal Administration Authority. 
1.3  Plaque assay of virus titration 
The viral titer was determined by plaque assay as described 
previously [12]. Dilutions of viral solutions were incubated 
on 80% confluent BHK-21 monolayers for 1 h at 37°C/5% 
CO2. Cultures were then overlaid with 2% agarose in 
DMEM containing 10% FBS. The monolayers were stained 
for 2 d using crystal violet with the agarose layers removed. 
1.4  Construction of mutated cDNA clones, production 
and identification of mutant viruses 
The full-length infectious clone of wild-type BJC3 was 
constructed as described previously [13] (Figure 1A). Mu-
tated cDNA clones were constructed by site-specific muta-     
genesis using a QuikChange® multi-site-directed mutagene-
sis kit (Stratagene) according to the manufacturer’s instruc-
tions. The specific single site mutation was performed at 
nucleotide 2904 using mutagenic primers (Table 1). For 
mutagenesis, a 1.3 kb Spe I-Sac I fragment containing the 
mutation was digested with the respective restriction enzymes 
from pWSKBJC3/w and subcloned into pBluescript® II SK+. 
Subsequent to site-specific mutagenesis, the mutant Spe 
I-Sac I fragments were digested, gel-purified and cloned back 
into pWSKBJC3/w to replace the corresponding fragment on 
the parental backbone and construct the mutated cDNA 
clones. These were pWSKBJC3m/I, pWSKBJC3m/A, 
pWSKBJC3m/S and pWSKBJC3m/P, containing the altered 
amino acids isoleucine, alanine, serine and proline, respec-
tively (Figure 1B). After in vitro transcription, the mRNA 
obtained from the mutated cDNA clones were transfected 
into BHK-21 monolayers to generate mutant progeny vi-
ruses. This was performed as previously described [13]. The 
rescued viruses were identified by a common indirect im-
munofluorescence assay (IFA), as described elsewhere [14].  
1.5  Sequencing of the single mutations in the derived 
viruses 
BHK-21 cells infected with the mutant viruses were treated 
with TRIzol Reagent (GIBCO) and the extracted total RNA 
was reverse transcribed with Superscript™ III (Invitrogen) 
using the specific primers listed in Table 1. The cDNA 
fragments covering nt 2329–3667 (containing the mutated 
nucleotides) were amplified by reverse transcription-poly-     
merase chain reaction (RT-PCR). The gel-purified PCR 
products were sequenced (Invitrogen, Beijing, China) to 
confirm the presence of the mutations. 
1.6  One-step growth kinetics for the viruses 
BHK-21 cell monolayers were infected at a multiplicity of 
infection (MOI) of 10 in 96-well plates. Following adsorp-
tion for 1 h at 37°C, the monolayers were washed three 
times with phosphate-buffered saline (PBS, pH 7.4), and 
100 μL of complete DMEM supplemented with 2% FBS. 
At each time point, triplicate or quadruplicate wells were 
harvested and freeze-thawed three times, with total virus 
yields determined by plaque assay. The growth kinetics for 
each virus was determined twice.  
1.7  Pathogenicity analyses of the EMCV variants 
Sixty mice were randomly allocated to six groups (10 mice  
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Figure 1  Schematic diagram for constructing full-length cDNA clones of BJC3 and mutant viruses. A, Capital letters (A, B and C) indicate the overlapping 
segments amplified from the BJC3 genome. A Cla I restriction site was added to the 5′ end of segments A and B to facilitate the A-B assembly and an EcoR I 
cleavage site was created by PCR mutagenesis for B-C ligation and genetic detection of rescued virus. Numbers below the restriction sites represent the 
nucleotide position of the BJC3 genome. B, A Spe I-Sac I segment containing the area of interest was excised from pWSKBJC3/w, cloned into  
pBluescript® II SK+, mutated by corresponding synthetic oligonucleotides and cloned back to construct the full length cDNA clones of mutant viruses. 
Table 1  Primers used in this study 
Primera) Positionb) Sequence (5′–3′) Use 
DetF 2637−2655 AGACGCAACTGCTGACTT Sequencing 
DetR 3498−3517 ACAATCTAACCTCCAAACC  
   Codon change 
SerF  AATGGAAATGAGGAGTCCTCAAAAGTCTTTCCGC ACC TCC→  
SerR  GCGGAAAGACTTTTGAGGACTCCTCATTTCCATT  
AlaF  AATGGAAATGAGGAGGCCTCAAAAGTCTTTCCGC ACC GCC→  
AlaR  GCGGAAAGACTTTTGAGGCCTCCTCATTTCCATT  
IleF  AATGGAAATGAGGAGATCTCAAAAGTCTTTCCGC ACC ATC→  
IleR  GCGGAAAGACTTTTGAGATCTCCTCATTTCCATT  
ProF  AATGGAAATGAGGAGCCCTCAAAAGTCTTTCCGC ACC CCC→  
ProR  GCGGAAAGACTTTTGAGGGCTCCTCATTTCCATT  
a) F refers to the forward PCR primer and R stands for the reverse PCR primer. b) Numbers represent the nucleotide positions within the genome of 
BJC3 (GenBank accession No. DQ464062). 
 
 
per group), and each group was housed separately in differ-
ent isolators. Each mouse was intraperitoneally inoculated 
with 0.2 mL of virus containing 5×105 plaque forming units 
(PFU; high dose). The mice in the control group were ad-
ministered the same volume of DMEM-2% FBS. The in-
oculation trial using the virus containing 2500 PFU (low 
dose) was designed as described above. Clinical signs in the 
inoculated mice were observed for two weeks post-inocula-     
tion (pi). 
1.8  Virus titration in tissues of inoculated mice, histo-
pathology and immunohistochemistry examination 
Twenty-four mice were used for the inoculation trial of each 
rescued virus. Each mouse was infected with 0.2 mL of vi-
rus containing 2000 PFU, and six mice in each group were 
euthanized on days 1, 3, 5 and 7 pi. Three mice were inocu-
lated with 0.2 mL of DMEM-2% FBS as a negative control, 
and were sacrificed at the end of the trial. The brains and 
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hearts were aseptically collected, weighed, and homoge-
nized in DMEM-2% FBS. The homogenates were 
freeze-thawed three times, titrated on BHK-21 monolayers 
by plaque assay and genomic copy numbers of rescued vi-
ruses were quantified by quantitative real-time RT-PCR 
(qPCR) as described previously [14]. Total RNA was ex-
tracted from the freeze-thawed homogenates and re-
verse-transcribed into cDNA using Oligo-d(T). The qPCRs 
were performed in a reaction volume containing cDNA 
template, specific primers (EMCV: 5′-TGAGTCATTAGC- 
CATTTCAACCCA-3′ and 5′-CGTGAGATACAAACCCG- 
CCCTA-3′; β-actin: 5′-TCATCACTATTGGCAACGAGC- 
3′ and 5′-GAGGTCTTTACGGATGTCAACG-3′) and SYBR® 
Green Real-time PCR Master Mix (TOYOBA Co., Ltd., 
Osaka, Japan) according to the manufacturer’s recommen-
dations. The relative genomic copies of the viruses were 
normalized to mRNA from the β-actin gene.  
Additionally, brains and hearts of the infected mice in the 
viral titration experiments were collected on days 3 and 5 pi, 
fixed in 4% buffered paraformaldehyde and embedded in 
paraffin. Sections were stained with hematoxylin and eosin 
and observed using microscopy. The extent of cellular deg-
radation and tissue lesions was evaluated. Histological 
scoring of brain samples was performed as follows: 0, no 
visible changes; 0–1, minor changes in cell population; 1–2, 
meningitis, mild cellular infiltrates; 2–3, meningitis, 
perivascular cuffing, moderate lymphocytic infiltrates, glio-
sis; 3–4, local neuronal degeneration and necrosis, cerebral 
microvascular exudation and hemorrhage; 4–5, extensive 
neuronal death, diffuse encephalitis, structural disorder, 
tissue degradation and atrophy. The inflammatory score of 
the heart was determined as described elsewhere [15] (0, no 
lesions; 1, lesions involving <25%; 2, lesions involving 
25%–50%; 3, lesions involving 50%–75%; 4, lesions in-
volving 75%–100%).  
For immunohistochemistry, cells positive for the pres-
ence of virus were detected by a standard two-step tech-
nique using a horseradish peroxidase-labeled (HRP) secon-
dary antibody. A monoclonal antibody against VP1 was 
used as the primary antibody at a dilution of 1/600. Depar-
affinized brain and heart sections were incubated with 10% 
normal goat serum for 30 min to block nonspecific binding. 
Diluted primary antibodies were added to the slides for 24 h 
at 4°C, followed by a 1/100 dilution of HRP-goat anti-    
mouse secondary antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) for 30 min at room temperature. The 
slides were incubated with 3,3′-diaminobenzidine (DAB) 
substrate as prescribed and the reaction was stopped by 
washing the slides in PBS. After dehydration, cover slips 
were applied to the slides and enumeration performed by 
light microscopy. The number of antigen-positive cells from 
10 fields of view was combined when a single section was 
observed and averaged over three coronal brain sections per 
mouse from six infected mice. 
1.9  Statistical analysis 
Data were expressed as mean±SD. The significance of the 
variability among the trials was determined by one-way or 
two-way analysis of variance using GraphPad Prism (ver-
sion 4.0). Differences were considered statistically signifi-
cant at a P-value less than 0.05. 
2  Results 
2.1  Identification of the viruses rescued from the con-
structed infectious cDNA clones 
Viable viruses were successfully rescued from the con-
structed full-length wild-type cDNA clone (pWSKBJC3/w) 
of BJC3 and its mutated cDNA clones (pWSKBJC3m/I, 
pWSKBJC3m/A, pWSKBJC3m/S and pWSKBJC3m/P) 
after in vitro transfection on BHK-21 cells. The rescued 
virus from the wild-type cDNA clone was designated as 
RvBJC3W, and the viruses rescued from the four mutated 
cDNA clones were individually designated as T1100I, 
T1100A, T1100S and T1100P. All the rescued viruses could 
replicate stably and generate typical cytopathic effects 
(CPEs) in BHK-21 cells. BHK-21 cells infected with the 
rescued viruses were stained with a monoclonal antibody 
specific for the VP1 of EMCV (Figure 2A). To evaluate the 
genetic stability of each point mutation following passage, 
we performed four consecutive passages of the rescued vi-
ruses in BHK-21 cells. The presence of the mutated nucleo-
tides for each rescued virus was confirmed by sequencing 
the amplified fragment from RT-PCR (data not shown). 
2.2  Rescued wild-type and mutant viruses replicate 
similarly in BHK-21 cells with different plaque mor-
phology 
To determine whether the EMCV replication in vitro could 
be affected by amino acid substitutions, we performed virus 
plaque assays and one-step growth kinetics in BHK-21 cells. 
Compared with RvBJC3W, the four mutant viruses showed 
differences in plaque size. Serine- (T1100S) and alanine-   
mutated (T1100A) viruses produced larger plaques with a 
size of 8–10 mm, similar to RvBJC3W. Isoleucine- (T1100I) 
and proline-mutated (T1100P) viruses generated approxi-
mately 60% smaller plaques, with a size of 4–5 mm (Figure 
2B). One-step growth kinetic assays indicated that the four 
mutant viruses exhibited growth curves similar to 
RvBJC3W (Figure 2C).  
2.3  Rescued mutant viruses T1100I and T1100P 
caused a reduced mortality in mice 
To analyze the virulence of mutant variants, eight-week-old 
male BALB/c mice were intraperitoneally inoculated with 
the mutated viruses, and the survival rates were observed.  
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Figure 2  Replication of RvBJC3W and mutant viruses in BHK-21 cells. A, IFA identification of the parental and mutant viruses. BHK-21 cells were in-
fected with viruses at an MOI of one and incubated with a VP1 monoclonal antibody at 6 h post-infection. B, Plaque morphology of the rescued viruses. C, 
One-step growth curve of the rescued viruses. The viral titers were determined by plaque assay. The growth curves of different viruses were comparable  
(P>0.05). The data shown are mean±SD (error bars) for triplicate independent trials. 
 
Figure 3  Survival curves of mice inoculated with the rescued viruses 
(n=10). A, Inoculation of 5×105 PFU of virus. B, Inoculation of 2500 PFU  
of virus. 
Under the high dose conditions, mice inoculated with 
RvBJC3W, T1100S and T1100A developed clinical signs 
within two days pi and began to die on days 3 (T1100S, 
T1100A) and 4 (RvBJC3W) pi. All mice died within 10 
days pi, while mice inoculated with T1100I and T1100P had  
a survival rate of 60% at the end of the two-week observa-
tion period despite similar clinical symptoms (Figure 3A). 
For the low dose groups, the onset of encephalitic symp-
toms was delayed. The first death in RvBJC3W-, T1100S- 
and T1100A-infected groups occurred on day 5 pi and the 
mortality rate in these three groups was 50%, 100% and 
80%, respectively, over the two week observation period. 
T1100I- and T1100P-infected mice barely had visible ab-
normal clinical reactions, and presented a survival rate of 
100% and 80%, respectively (Figure 3B). The survival rate 
of mice infected with T1100I was significantly higher than 
that of RvBJC3W-infected mice at the high (P<0.0001) and 
low dose (P<0.0001) challenges. T1100P-infected mice also 
showed significantly lower mortality rate than RvBJC3W 
under high (P=0.0016) and low dose (P=0.0036) conditions. 
In addition, no significant survival differences were ob-
served among RvBJC3W-, T1100S- and T1100A-infected 
mice (P>0.5). All mice in the control group remained 
healthy and survived the entire experimental period. These 
data indicate that the isoleucine- and proline-mutations re-
sulted in obviously reduced pathogenicity of EMCV BJC3 
in mice. 
2.4  Rescued mutant viruses T1100I and T1100P exhib-
ited lower virus loads in the target organs of inoculated 
mice 
To examine the extent of the replication of mutant viruses in 
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vivo, we infected the BALB/c mice and determined the lev-
els of infectious viruses in their brains and hearts on days 1, 
3, 5 and 7. Mice were intraperitoneally inoculated with 
2000 PFU of each rescued virus. The RvBJC3W-, T1100S- 
and T1100A-infected mice developed neurological disorders 
after day 5 pi, but no mortality was observed within 7 d. No 
obvious clinical signs were observed in T1100I- and 
T1100P-infected groups. As shown in Figure 4A, the viral 
titers in T1100I- and T1100P-infected mice were undetect-
able by plaque assay on day 1 pi while viruses in T1100S- 
and T1100A-infected mice could be titrated. Compared with 
the parental RvBJC3W, T1100S-infected mice had signifi-
cantly higher viral loads in brains on days 1 and 3 pi 
(P<0.001, P<0.05), whereas T1100I- and T1100P-infected 
mice had significantly lower viral loads in the brains on 
days 3, 5 and 7 pi (P<0.001). Viral titers in the brains of 
T1100I- and T1100P-infected mice were approximately 
100−10000-fold lower than that of RvBJC3W-infected mice 
on days 3 and 7 pi. Viral genomic RNA levels in the brains 
of the infected mice showed similar tendencies (Figure 4C). 
The number of genomic copies of T1100S in the brains of 
infected mice was significantly higher than that of parental 
RvBJC3W-infected mice on days 1 and 3 pi (P<0.05). The 
T1100I- and T1100P-infected mice contained a lower num- 
ber of genomic copies compared with parental RvBJC3W-     
infected mice (P<0.001). The viral titers of parental and 
mutant viruses decreased on day 7 pi (Figure 4A), and may 
be due to an increase in the titer of antibodies against vi-
ruses, as previously reported in a study on the diabetogenic 
EMC-D strain [16]. By contrast, the viral loads in the hearts 
showed no differences among the mice infected with the 
rescued viruses (Figure 4B and D). Viral loads and genomic 
copies were not detected in control mice. These data re-
vealed that the significant differences in viral loads in the 
brains of infected mice had a strong correlation with the 
observed mortalities.  
2.5  Mutated T1100I and T1100P showed alleviated 
cerebral tissue lesions in mice 
To determine whether the isoleucine and proline mutations 
prevent virus dissemination and restrict virus-induced tissue 
damage, we performed histological examinations of the 
target organs in infected mice. Histopathological changes 
were observed in the cerebral cortex, hypothalamus and hip-
pocampus of brains. In the mice infected with RvBJC3W, 
T1100S and T1100A, severe and concentrated neuronal 
damage including nuclei pyknosis, degeneration, necrosis  
 
 
Figure 4  Titration of parental RvBJC3W and mutant viruses in target organs of mice inoculated with the rescued viruses. Viral titers in target organs were 
determined by plaque assay. A, Viral titers in brains of the inoculated mice. B, Viral titers in hearts of the inoculated mice. Viral genomic RNA levels were 
determined by quantitative real-time RT-PCR. C, Viral genomic RNA levels in brains. D, Viral genomic RNA levels in hearts. Data are expressed as  
mean±SD (error bars) (n=6). *, P<0.05; ***, P<0.001, compared with RvBJC3W. 
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and degradation (Figure 5A) was observed. By contrast, 
light and sporadic pathological changes, such as mild men-
ingitis, microvascular hemorrhaging and perineural space 
broadening could be observed in the cerebral cortex of 
T1100I and T1100P-infected mice (Figure 5B). Detailed 
histopathological scores are shown in Figure 6A. Although 
T1100S-infected mice had more severe brain damage com-
pared with parental RvBJC3W-infected mice on day 3 pi 
(P<0.05), no significant differences in the overall distribu-
tion and severity of the cerebral lesions were observed in 
T1100S- and T1100A-infected mice. By contrast, in 
T1100I- and T1100P-infected mice, degeneration and ne-
crosis of neurons were barely seen on day 3 pi (P<0.01) and 
only moderate inflammatory reactions could be seen on day 
5 pi (P<0.001), indicating that T1100I and T1100P caused 
less brain damage than RvBCJ3W. Histopathological ex-
amination of the heart sections revealed that all inoculated 
mice had very mild myocarditis, including mononuclear cell 
infiltration in a few and very modest myocardium lesions 
(data not shown). The lesion score was under one and 
showed no significant differences among all inoculated 
groups.  
Viral antigen localization and enumeration were per-
formed by immunohistochemistry. The results showed that 
positive cells in RvBJC3W-, T1100S- and T1100A-infected 




Figure 5  Neuropathology and immunohistochemistry of cerebral tissues in mice infected with the rescued virus. A and B, Pathological changes of T1100S 
and T1100I, respectively, on day 5 pi. D and E, Immunohistochemistry at the same infectious sites for T1100S and T1100I on day 5 pi. C and F, Control 
sections. G, Concentrated positive signals in local necrotic foci. H, Neurons were mostly, cytoplasmic staining of neurons. I, Antigen-positive signals in the  
endotheliocytes of capillaries. G–I, T1100S on day 3 pi. Magnification: A–F, ×200; G, ×100; H and I, ×400. 
 
Figure 6  Cerebral histopathological scores of mice infected with the rescued viruses. A, Histopathological evaluation of cerebral lesions. B, Detection of 
EMCV antigen-positive cells in the brains by immunohistochemistry. Data are expressed as mean±SD (error bars) (n=6). *, P<0.05; **, P<0.01; ***,  
P<0.001. 
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layer of cerebral cortices on day 3 pi (Figure 5D and G), 
while positive cells in T1100I- and T1100P-infected mice 
were hardly observed (Figure 5E). Viral antigens were 
found in either microglial cells or macrophages; however, 
neurons in the cerebral hemisphere of RvBJC3W-, T1100S- 
and T1100A-infected mice were mostly affected (Figure 
5H). Positive signals were also seen in the endotheliocytes 
of capillaries in the cerebral cortex (Figure 5I). On day 5 pi, 
more and stronger positive signals were found in 
RvBJC3W-, T1100S- and T1100A-infected mice, whereas 
only a few positive cells were seen in T1100I- and 
T1100P-infected mice. Positive cell enumeration showed 
significantly more infected neural cells in RvBJC3W-, 
T1100S- and T1100A-infected mice on day 3 (P<0.01) and 
5 (P<0.001) pi (Figure 6B).  
3  Discussion 
3.1  Selection of animal model and position for 
site-directed mutagenesis 
Our previous studies indicated that strain BJC3 used in this 
study was fatal to mice because of its strong neurovirulence, 
but not to piglets [17]. Thus, analyzing the associated mo-
lecular mechanisms for pathogenicity was essential using a 
mouse model. Because the amino acid sequence of VP1 for 
EMCV BJC3 shared 96.4% homology with that of Mengo 
virus, these two viruses have remarkable similarity with 
respect to conformational structure of their capsid protein. 
Thus, the already known VP1 structure of Mengo virus 
could be used as a substitution analogy for a BJC3 VP1 
molecular model. In addition, the structural comparison 
between Mengo virus and TMEV, a well-investigated virus 
for CNS disease models, showed a similar conformation of 
loop II (residues 94–112 in TMEV and 90–110 in Mengo 
virus) on the external surface of the virion [18]. Based on 
the reported structures for Mengo, molecular modeling 
analysis by Collaborative Computational Project No. 4 
(CCP4; version 6.11) indicates that EMCV VP1 loop II is on 
the periphery of a deep depression on the surface of the virion 
that has been proposed as a probable receptor binding site and 
the threonine is at the top. Previous evidence has shown that 
Thr-101 of TMEV VP1 is a disease determinant [19]. There-
fore, we focused on the threonine at position 100 of VP1 in 
BJC3 as the target of mutagenesis. Among all possible mu-
tations, by changing the first and second base of the original 
ACC codon, we selected serine, alanine, isoleucine and 
proline as representatives of different chemical traits. Simi-
lar to threonine, serine is also classified as a polar amino 
acid bearing a hydroxyl group. Alanine is a small nonpolar 
aliphatic amino acid. Another hydrophobic amino acid, iso-
leucine, was chosen as mutation existing naturally at the 
same site in VP1 of Mengo viruses and led to a conforma-
tional change that conferred an ability to avoid monoclonal 
antibody neutralization [20]. The proline mutation is an 
attempt to act as a structural disruptor for possible ring for-
mation. 
3.2  Amino acid substitutions altered the in vivo repli-
cation of EMCV in mice 
Although the mutant viruses showed similar one-step 
growth curves, the different plaque size might be an impli-
cation of altered replicative efficiency and lytic ability in 
BHK-21 cells between mutated variants. It was further re-
flected in the in vivo viral loads that the mutant viruses, 
T1100S and T1100A, with larger plaque size, maintained 
completely efficient replication in mice brains, similar to 
the rescued wild-type virus RvBJC3W. The smaller plaque 
forming mutant viruses, T1100I and T1100P, showed sig-
nificantly deficient cerebral growth. Despite the viral titers 
of mutant viruses displaying no significant differences in 
the mouse heart, we cannot exclude the possible influence 
of viral replication on myocardial tissues. All mutant vi-
ruses, as well as the parental wild-type RvBJC3W, repli-
cated at an extremely low level in hearts. It seems that the 
BJC3 strain has poor myocardial proliferation, similar to 
some previously reported EMCV isolates [3]. The discrep-
ancy between in vivo and in vitro kinetics might be related to 
the different virus receptor(s) on BHK-21 cells and mice tar-
get cells, as suggested previously with TMEV variants [21]. 
Further histological analyses demonstrated an obvious cor-
relation between damage in target organs, overall in vivo 
replication, and certain strain-dependent properties.  
3.3  Amino acid mutations possibly alter virus replica-
tion in certain cerebral cells 
Immunohistochemistry results revealed that the viral repli-
cation of highly pathogenic mutants like T1100S and 
T1100A in the cerebral cells, especially the neurons, resem-
bled that observed for wild-type virus. By contrast, the rep-
lication of less pathogenic mutants in neurons appears to be 
minimal, suggesting that the infection/replication of T1100I 
and T1100P might be severely compromised in neurons in 
vivo. Combined with the disparity of viral load in the brains 
and hearts of infected mice, a more feasible explanation for 
the different pathologies of T1100 mutants would be altered 
viral replication in mouse cerebral cells, especially neurons, 
attributable to the single amino acid substitution. Thus, we 
hypothesize that the threonine at position 100 of VP1 likely 
participates in viral interaction of neuronal cells and some-
how influences viral proliferation and spread in the brain. 
The actual mechanism associated with this alteration in 
pathogenicity alteration requires further exploration. Vi-
ruses with isoleucine and proline mutations appear to have a 
reduced ability to grow in the brains of infected mice, but 
cause mortality when inoculated at a high dose. Unlike 
Ala152 of VP1, which is a determinant of viral infection for 
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pancreatic β-cells and gain or loss of diabetogenicity in 
EMC-D [7], it seems that Thr100 in BJC3 VP1 is not the 
only factor determining the EMCV cerebral replication and 
viral pathogenicity. 
4  Conclusion 
Our findings provide direct evidence that substitutions of 
the amino acid at position 100 of VP1 could influence the 
pathogenicity of EMCV BJC3 by affecting viral replication 
in the brain, especially in neurons, of infected mice. 
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